Nanobiotix (ADR)
Develops radiotherapy-activated nanoparticle candidates for solid tumors.
$40.83
After-hours close−0.25 (−0.61%)
At close$41.08(−9.03%)
Something off on this page? Send us feedback.
Breakdown13F · Form 4
Institutions 11.26%Insiders —
Shares outstanding 50.60M · Float 41.45M · 81.9% free float
Institutions13F, as of Mar 31, 2026
15 holders · 5.70M shares · 2 new positions · 5 increased · 5 reduced · 1 closed
| Holder | Shares | % outstanding | Chg q/q | Filed |
|---|---|---|---|---|
| Johnson & Johnson | 5.62M | 11.11% | 0 | May 13, 2026 |
| Morgan Stanley | 36.3K | 0.07% | +13.4K | May 15, 2026 |
| Optiver Holding B.V. | 13.5K | 0.03% | −2.7K | Jun 2, 2026 |
| Marshall Wace, LLP | 9.2K | 0.02% | −261 | May 15, 2026 |
| UBS Group AG | 5.6K | 0.01% | +4.0K | May 5, 2026 |
| BNP Paribas Arbitrage, SNC | 3.6K | 0.01% | −41 | May 12, 2026 |
| Rhumbline Advisers | 2.3K | 0.00% | −61 | May 12, 2026 |
| Royal Bank of Canada | 1.8K | 0.00% | −800 | May 15, 2026 |
Beneficial owners13D/G · 5% or more, as filed
| Holder | % of class | Shares | Form | Filed |
|---|---|---|---|---|
| Invus Public Equities, L.P. | 8.90% | 4.23M | 13G | Apr 17, 2025 ↗ |
InsidersForm 4
Latest trades
Nothing filed in the last 12 months.
CongressHouse and Senate disclosures
Not reported.